I am a
Home I AM A Search Login

Papers of the Week

2019 Oct 01

JAMA Oncol



Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial.


O'Reilly EM, Oh D-Y, Dhani N, Renouf DJ, Lee M A, Sun W, Fisher G, Hezel A, Chang S-C, Vlahovic G, Takahashi O, Yang Y, Fitts D, Philip P A
JAMA Oncol. 2019 Oct 01; 5(10):1431-1438.
PMID: 31318392.


New therapeutic options for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) are needed. This study evaluated dual checkpoint combination therapy in patients with mPDAC.